Press releases
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Aug 11, 2010
Boston Scientific Corporation (NYSE: BSX) today announced that it has been notified by the U.S. Food and Drug Administration that all issues cited...
-
Aug 3, 2010EVOLVE trial to evaluate Company's fourth-generation SYNERGY™ drug-eluting coronary stent
Boston Scientific Corporation (NYSE: BSX) today announced the start of patient enrollment in the EVOLVE clinical trial, which is designed to assess...
-
Jul 29, 2010Company now offers pain specialists the most comprehensive portfolio of SCS percutaneous leads
Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration approval of two spinal cord stimulation (SCS) leads for...
-
Jul 29, 2010
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the BMO Capital Markets Healthcare Conference on August 5th in New York....
-
Jul 26, 2010Company expands market-leading family of neurovascular stents
Boston Scientific Corporation (NYSE: BSX) today announced the U.S. and European launches of the Neuroform EZ™ Stent System, its fourth-generation...